BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25900621)

  • 1. The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
    Korf B; Ahmadian R; Allanson J; Aoki Y; Bakker A; Wright EB; Denger B; Elgersma Y; Gelb BD; Gripp KW; Kerr B; Kontaridis M; Lazaro C; Linardic C; Lozano R; MacRae CA; Messiaen L; Mulero-Navarro S; Neel B; Plotkin S; Rauen KA; Roberts A; Silva AJ; Sittampalam SG; Zhang C; Schoyer L
    Am J Med Genet A; 2015 Aug; 167A(8):1741-6. PubMed ID: 25900621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
    Stevenson DA; Schill L; Schoyer L; Andresen BS; Bakker A; Bayrak-Toydemir P; Burkitt-Wright E; Chatfield K; Elefteriou F; Elgersma Y; Fisher MJ; Franz D; Gelb BD; Goriely A; Gripp KW; Hardan AY; Keppler-Noreuil KM; Kerr B; Korf B; Leoni C; McCormick F; Plotkin SR; Rauen KA; Reilly K; Roberts A; Sandler A; Siegel D; Walsh K; Widemann BC
    Am J Med Genet A; 2016 Aug; 170(8):1959-66. PubMed ID: 27155140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
    Rauen KA; Schoyer L; McCormick F; Lin AE; Allanson JE; Stevenson DA; Gripp KW; Neri G; Carey JC; Legius E; Tartaglia M; Schubbert S; Roberts AE; Gelb BD; Shannon K; Gutmann DH; McMahon M; Guerra C; Fagin JA; Yu B; Aoki Y; Neel BG; Balmain A; Drake RR; Nolan GP; Zenker M; Bollag G; Sebolt-Leopold J; Gibbs JB; Silva AJ; Patton EE; Viskochil DH; Kieran MW; Korf BR; Hagerman RJ; Packer RJ; Melese T
    Am J Med Genet A; 2010 Jan; 152A(1):4-24. PubMed ID: 20014119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
    Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
    Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.
    Allanson JE
    Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
    Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
    J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RASopathies.
    Rauen KA
    Annu Rev Genomics Hum Genet; 2013; 14():355-69. PubMed ID: 23875798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International meeting on Wolf-Hirschhorn syndrome: Update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay.
    Nevado J; Ho KS; Zollino M; Blanco R; Cobaleda C; Golzio C; Beaudry-Bellefeuille I; Berrocoso S; Limeres J; Barrúz P; Serrano-Martín C; Cafiero C; Málaga I; Marangi G; Campos-Sánchez E; Moriyón-Iglesias T; Márquez S; Markham L; Twede H; Lortz A; Olson L; Sheng X; Weng C; Wassman ER; Newcomb T; Wassman ER; Carey JC; Battaglia A; López-Granados E; ; Douglas D; Lapunzina P
    Am J Med Genet A; 2020 Jan; 182(1):257-267. PubMed ID: 31769173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.
    Pierpont EI; Bennett AM; Schoyer L; Stronach B; Anschutz A; Borrie SC; Briggs B; Burkitt-Wright E; Castel P; Cirstea IC; Draaisma F; Ellis M; Fear VS; Frone MN; Flex E; Gelb BD; Green T; Gripp KW; Khoshkhoo S; Kieran MW; Kleemann K; Klein-Tasman BP; Kontaridis MI; Kruszka P; Leoni C; Liu CZ; Merchant N; Magoulas PL; Moertel C; Prada CE; Rauen KA; Roelofs R; Rossignol R; Sevilla C; Sevilla G; Sheedy R; Stieglitz E; Sun D; Tiemens D; White F; Wingbermühle E; Wolf C; Zenker M; Andelfinger G
    Am J Med Genet A; 2024 Apr; 194(4):e63477. PubMed ID: 37969032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAS diseases in children.
    Niemeyer CM
    Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autism traits in the RASopathies.
    Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA
    J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on the treatment of RASopathies].
    Duat-Rodriguez A; Hernandez-Martin A
    Rev Neurol; 2017 May; 64(s03):S13-S17. PubMed ID: 28524213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
    Rauen KA; Schoyer L; Schill L; Stronach B; Albeck J; Andresen BS; Cavé H; Ellis M; Fruchtman SM; Gelb BD; Gibson CC; Gripp K; Hefner E; Huang WYC; Itkin M; Kerr B; Linardic CM; McMahon M; Oberlander B; Perlstein E; Ratner N; Rogers L; Schenck A; Shankar S; Shvartsman S; Stevenson DA; Stites EC; Stork PJS; Sun C; Therrien M; Ullian EM; Widemann BC; Yeh E; Zampino G; Zenker M; Timmer W; McCormick F
    Am J Med Genet A; 2018 Dec; 176(12):2924-2929. PubMed ID: 30302932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
    Zenker M
    Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
    Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D
    Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
    Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
    Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of craniofacial and dental findings of the RASopathies.
    Cao H; Alrejaye N; Klein OD; Goodwin AF; Oberoi S
    Orthod Craniofac Res; 2017 Jun; 20 Suppl 1(Suppl 1):32-38. PubMed ID: 28643916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.